|
Combined Opioidergic and Beta-Adrenergic Drugs for
Cancer and Immune Diseases
Figure 1. (Left) Combined, synergistic treatment with naltrexone (NTX), propranolol (PRO), and Anti-PD1 antibody shows decrease in tumor size, by volume. (Right) Combined treatment of NTX, DPDPE, and PRO similarly decreases tumor size compared to controls.
Invention Summary:
One of the major cancer therapy approaches that is being...
Published: 1/25/2024
|
Inventor(s): Dipak Sarkar
Keywords(s): Anti-cancer, Small molecules
Category(s): Technology Classifications > Cancer, Technology Classifications > Healthcare & Life Sciences
|
